GOLDMAN SACHS GROUP INC - VANDA PHARMACEUTICALS INC ownership

VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 203 filers reported holding VANDA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of VANDA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,225,528
-47.9%
1,672,576
-20.5%
0.00%
-66.7%
Q2 2023$13,862,005
+23.7%
2,103,491
+27.4%
0.00%
+50.0%
Q1 2023$11,209,862
+1.7%
1,650,937
+10.7%
0.00%0.0%
Q4 2022$11,020,219
-34.6%
1,491,234
-12.5%
0.00%
-50.0%
Q3 2022$16,844,000
-15.7%
1,704,914
-7.0%
0.00%
-20.0%
Q2 2022$19,976,000
-6.1%
1,832,681
-2.5%
0.01%
+25.0%
Q1 2022$21,268,000
-20.3%
1,880,500
+10.5%
0.00%
-20.0%
Q4 2021$26,693,000
+90.9%
1,701,256
+108.5%
0.01%
+66.7%
Q3 2021$13,983,000
-1.3%
815,825
+23.9%
0.00%0.0%
Q2 2021$14,162,000
+72.6%
658,412
+20.5%
0.00%
+50.0%
Q1 2021$8,206,000
-22.6%
546,349
-32.2%
0.00%
-33.3%
Q4 2020$10,596,000
+37.6%
806,337
+1.2%
0.00%
+50.0%
Q3 2020$7,700,000
+29.6%
797,090
+53.5%
0.00%0.0%
Q2 2020$5,942,000
-9.6%
519,384
-18.1%
0.00%0.0%
Q1 2020$6,574,000
-40.3%
634,547
-5.5%
0.00%
-33.3%
Q4 2019$11,018,000
-15.3%
671,386
-31.4%
0.00%
-25.0%
Q3 2019$13,002,000
+41.2%
979,117
+49.8%
0.00%
+33.3%
Q2 2019$9,210,000
-39.7%
653,687
-21.3%
0.00%
-40.0%
Q1 2019$15,286,000
-11.6%
830,735
+25.6%
0.01%
-16.7%
Q4 2018$17,286,000
+28.1%
661,535
+12.5%
0.01%
+100.0%
Q3 2018$13,497,000
+246.6%
588,079
+187.7%
0.00%
+200.0%
Q2 2018$3,894,000
+0.6%
204,419
-11.0%
0.00%0.0%
Q1 2018$3,872,000
-48.6%
229,813
-53.6%
0.00%
-50.0%
Q4 2017$7,526,000
-16.6%
495,158
-1.7%
0.00%0.0%
Q3 2017$9,021,000
+44.6%
503,908
+31.6%
0.00%
+100.0%
Q2 2017$6,240,000
+33.7%
382,890
+14.9%
0.00%0.0%
Q1 2017$4,667,000
-70.4%
333,368
-66.3%
0.00%
-75.0%
Q4 2016$15,757,000
-30.4%
987,909
-27.4%
0.00%
-42.9%
Q3 2016$22,645,000
+271.5%
1,360,862
+149.8%
0.01%
+600.0%
Q2 2016$6,096,000
+46.0%
544,786
+9.1%
0.00%0.0%
Q1 2016$4,175,000
+79.0%
499,406
+99.4%
0.00%
Q4 2015$2,332,000
-18.8%
250,462
-1.6%
0.00%
-100.0%
Q3 2015$2,872,000
-92.6%
254,630
-91.6%
0.00%
-90.9%
Q2 2015$38,634,000
-5.3%
3,044,386
-30.6%
0.01%
-21.4%
Q1 2015$40,809,000
+939.7%
4,387,992
+1501.2%
0.01%
+1300.0%
Q4 2014$3,925,000
-54.0%
274,043
-66.7%
0.00%
-50.0%
Q3 2014$8,538,000
-32.7%
822,648
+4.9%
0.00%
-50.0%
Q2 2014$12,685,000
-49.1%
783,971
-48.8%
0.00%
-55.6%
Q1 2014$24,906,000
+67.1%
1,532,680
+27.6%
0.01%
+80.0%
Q4 2013$14,901,000
-19.5%
1,200,749
-29.0%
0.01%
-28.6%
Q3 2013$18,518,000
+898.8%
1,691,126
+636.7%
0.01%
+600.0%
Q2 2013$1,854,000
+3930.4%
229,552
+1923.0%
0.00%
Q3 2012$46,000
-8.0%
11,347
+0.1%
0.00%
Q2 2012$50,000
-50.0%
11,335
-45.5%
0.00%
Q1 2012$100,00020,7850.00%
Other shareholders
VANDA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Signpost Capital Advisors, LP 1,688,952$27,327,00010.37%
Palo Alto Investors LP 3,240,424$52,430,0003.90%
Parametrica Management Ltd 12,509$202,0001.53%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,740,400$28,160,0001.08%
PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC 557,100$9,014,0001.07%
Westend Capital Management, LLC 64,086$841,0001.00%
WALL STREET ASSOCIATES 702,700$11,370,0000.98%
Baker Brothers Advisors 4,372,153$70,741,0000.87%
Iguana Healthcare Management, LLC 100,000$1,618,0000.76%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,085,301$17,560,0000.71%
View complete list of VANDA PHARMACEUTICALS INC shareholders